John G Ullman & Associates Inc Moderna, Inc. Transaction History
John G Ullman & Associates Inc
- $630 Million
- Q1 2024
A detailed history of John G Ullman & Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, John G Ullman & Associates Inc holds 11,400 shares of MRNA stock, worth $1.33 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
11,400
Previous 3,650
212.33%
Holding current value
$1.33 Million
Previous $362,000
235.36%
% of portfolio
0.19%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
1,037Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.23 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.57 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.97 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.69 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.13 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...